Alnylam Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) Transcript
Good afternoon, everyone. Thanks for joining the 20th Annual Needham Healthcare Conference. My name is Joey Stringer, and I'm one of the biotech analysts at Needham & Company. It's my pleasure to introduce our next presenting company, Alnylam Pharmaceuticals. Joining us today from Alnylam is CEO, John Maraganore. And we'll start with a company overview, followed by a Q&A session. So for those of you joining on the webcast, if you [wanted the answer to a question], please do so at any time, you can submit a question using the chat feature in your web browser. So with that, we'll get started. I'll turn it over to John for a company overview.
Great. And Joe, we were just going to do more of a fireside chat, and so I'm going to do more of a verbal, again, on where the company is for everybody. Obviously, Alnylam is really at an exciting stage of its development. We have now brought 4 RNAi
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
